ISG20L2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.005400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.066000E-01
Normal-vs-Stage2
4.503600E-01
Normal-vs-Stage3
4.789200E-01
Normal-vs-Stage4
9.489900E-02
Stage1-vs-Stage2
8.130600E-01
Stage1-vs-Stage3
1.355030E-01
Stage1-vs-Stage4
1.465760E-01
Stage2-vs-Stage3
1.048610E-01
Stage2-vs-Stage4
1.798480E-02
Stage3-vs-Stage4
3.036000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.315600E-01
Normal-vs-AfricanAmerican
6.258400E-02
Normal-vs-Asian
6.095600E-01
Caucasian-vs-AfricanAmerican
2.667400E-01
Caucasian-vs-Asian
8.480000E-01
AfricanAmerican-vs-Asian
3.948200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.685000E-01
Normal-vs-Female
5.545800E-01
Male-vs-Female
5.452800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.913600E-01
Normal-vs-Age(41-60Yrs)
2.841400E-01
Normal-vs-Age(61-80Yrs)
6.297800E-01
Normal-vs-Age(81-100Yrs)
5.581800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.764600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.881200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.796200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.825700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.617000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.435000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.396800E-01
Normal-vs-Daily Drinker
9.891600E-01
Normal-vs-Weekly Drinker
4.894400E-01
Normal-vs-Occasional Drinker
1.340190E-01
Normal-vs-Social Drinker
5.481400E-01
Non Drinker-vs-Daily Drinker
4.420200E-01
Non Drinker-vs-Weekly Drinker
4.089800E-01
Non Drinker-vs-Occasional Drinker
6.017800E-02
Non Drinker-vs-Social Drinker
8.658800E-01
Daily Drinker-vs-Weekly Drinker
1.477590E-01
Daily Drinker-vs-Occasional Drinker
6.998400E-03
Daily Drinker-vs-Social Drinker
3.340800E-01
Weekly Drinker-vs-Occasional Drinker
4.633800E-01
Weekly Drinker-vs-Social Drinker
5.044000E-01
Occasional Drinker-vs-Social Drinker
6.304300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.690000E-01
Normal-vs-Grade 2
6.955800E-01
Normal-vs-Grade 3
6.633600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.735800E-03
Grade 1-vs-Grade 3
5.202700E-03
Grade 1-vs-Grade 4
6.690000E-01
Grade 2-vs-Grade 3
5.032800E-01
Grade 2-vs-Grade 4
6.955800E-01
Grade 3-vs-Grade 4
6.633600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.733400E-01
Normal-vs-NonDiabetic
5.323600E-01
Diabetic-vs-NonDiabetic
2.970600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.872400E-01
Normal-vs-NoPancreatitis
5.618000E-01
Pancreatitis-vs-NoPancreatitis
6.844600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.716600E-01
Normal-vs-N1
4.983800E-01
N0-vs-N1
9.016800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.781800E-01
Normal-vs-TP53-NonMutant
4.834000E-01
TP53-Mutant-vs-TP53-NonMutant
4.418300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
